Pathway Genomics to participate in NASDAQ Fit Week

January 2, 2017 San Diego, CA – (BUSINESS WIRE) — Pathway Genomics, an innovative commercial-stage genomics company, announced today that they will be participating in the 7th annual NASDAQ Fit Week. PathwayFit®, their test that assesses 80 genetic markers to help personalize and optimize diet, nutrition, metabolic health and exercise regimes, will be featured at Fit Week. As part of the event, Pathway will be offering PathwayFit® for a special price of $199 during the month of January and will also kick off the “This Is My Pathway” video contest to help create awareness about making informed, proactive lifestyle decisions…

Read More

Pathway Genomics’ CIO, Dr. Michael Nova, to Present at the 2017 CES Digital Health Conference

December 28, 2016 San Diego, CA – (BUSINESS WIRE) — Pathway Genomics, a cutting-edge commercial-stage genomics company, announced today that Dr. Michael Nova, Chief Innovation Officer, will present and be a panelist at the 2017 CES Digital Health Conference in Las Vegas, Nevada. The Conference will be held January 4-8, 2017 at The Venetian Hotel…

Read More

Pathway Genomics to Present & Exhibit at The 24th Annual World Congress on Anti-Aging Medicine

December 8, 2016 San Diego, CA – (BUSINESS WIRE) — Pathway Genomics, an innovative commercial-stage genomics company, announced today that Dr. Michael Nova, Chief Innovation Officer, will present at the 24th Annual World Congress on Anti-Aging Medicine in Las Vegas, Nevada. Dr. Nova will present on Nutritional Genetics and Epigenetics in Diabetes and Obesity Management on Friday December 9th at 2:55pm in the Veronese Room (2503-4/2403-4) at the Venetian Hotel. Additionally, Pathway will be exhibiting at the conference in booth 3098…

Read More

Pathway Genomics’ Chief Financial Officer, Kamal Adawi, to present at the 28th Annual Piper Jaffray Healthcare Conference

November 28, 2016 San Diego, CA – (BUSINESS WIRE) — Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference. This conference will be held at The Lotte New York Palace in New York City on November 29th and 30th and the presentation will be made available on Pathway.com and Pathway’s social media…

Read More

Pathway Genomics’ Chief Financial Officer, Kamal Adawi to present at Canaccord Genuity Medical Technology & Diagnostics Forum

October 13, 2016 – SAN DIEGO–(BUSINESS WIRE)–Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, which will be held at the Westin Grand Central Hotel in New York City on Thursday, November 17, 2016…

Read More

G-TAC – M3 (a Sony Company) and Pathway Genomics Partner to Market CancerIntercept, BRCATrue® and Fitness Genetic Tests in Japan

July 19, 2016 – TOKYO | (BUSINESS WIRE) – G-TAC Co., Ltd. and M3, Inc. (an associated company of SONY) announced a strategic business partnership with Pathway Genomics to market fourteen tests including CancerIntercept™, BRCATrue®, PathwayFit®, SkinFit™ and other genetic tests through G-TAC’s genomics network of over 20,000 physicians in Japan….

Read More

Pathway Genomics Provides Updates for CancerIntercept Detect Clinical Program

May 26, 2016 – Pathway Genomics today provided an update on the clinical development program for its liquid biopsy, CancerIntercept™ Detect….

Read More

Pathway Genomics Debuts First Genomic Wellness App

January 7, 2016 – Pathway Genomics and IBM (NYSE: IBM) today unveiled at the Digital Health Summit at CES 2016 the closed-alpha…

Read More

Pathway Genomics Corporation Raises Over $40 Million In Series E Financing

January 05, 2016 – Pathway Genomics Corporation, a global precision medicine company with mobile health solutions, today announced it has successfully raised over $40 million in a Series E financing.

This brings the total investment into Pathway Genomics to over $130 million. Investors in this round of funding include IBM Watson,…

Read More

Former Administrator of the U.S. Small Business Administration Hector Barreto Joins Pathway Genomics’ Strategic Advisory Board

August 17, 2015 – Pathway Genomics, a global precision medical diagnostics company with mobile health applications designed to empower physicians and their patients to take control of their health and wellness, has announced today that Hector Barreto, the 21st Administrator of the U.S. Small Business Administration, has joined the Company’s Strategic Advisory Board…

Read More

Pathway Genomics Launches First Hispanic Targeted Screening Panel for BRCA1/2-Related Hereditary Cancers

June 2, 2015 – Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory, announced today the launch of BRCATrue Hispanic (8-Site), a site-specific genetic testing panel consisting of 8 recurrent BRCA1 and BRCA2 pathogenic variants found in individuals of Mexican and Hispanic descent…

Read More

Former Chairman of the Joint Chiefs of Staff U.S. General Peter Pace joins Pathway Genomics Board of Directors

May 19, 2015 – Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory announced today that the sixteenth Chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s Board of Directors…

Read More